The pharmaceutical landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a potential development. Unlike subcutaneous injections, this technique offers a less invasive way to provide https://hamzahlype536362.luwebs.com/41860810/glp-1-patches-a-new-approach-to-blood-sugar-control